| Financial Year |
March 31 2023 |
| Monetary Funds |
1,368,335,672.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
22,637,840.14 |
| Accounts Receivable |
1,499,169,566.47 |
| Advances to Suppliers |
94,284,526.47 |
| Other Receivables |
34,999,724.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
560,511,180.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,068,239.67 |
| Total Current Assets |
6,184,075,121.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
57,691,705.76 |
| Investment Properties |
18,736,656.83 |
| Fixed Assetes |
472,462,149.47 |
| Under-construction Projects |
1,582,811.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
94,474,683.36 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,454,982.59 |
| Deferred Income Tax Assets |
122,124,461.57 |
| Other Non-Current Assets |
49,809,431.07 |
| Sub-Total of Non-Current Assets |
835,926,343.04 |
| Total Assets |
7,020,001,465.01 |
| Short-Term Loans |
984,905,700.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
392,043,301.27 |
| Accounts Payable |
1,122,303,984.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,263,702.56 |
| Taxes Payable |
10,787,026.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,107,983.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,657,176.07 |
| Other Current Liabilities |
874,571,477.53 |
| Sub-Total of Current Liabilities |
3,869,521,537.43 |
| Long-term Loans |
402,935,111.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,207,162.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
430,837,903.73 |
| Total Liabilities |
4,300,359,441.16 |
| Paid-In Capital(Or Share Stock) |
538,799,978.00 |
| Capital Surplus |
946,968,865.01 |
| Surplus Reserve |
195,503,351.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,005,392,129.97 |
| Minority Stockholder's Interest |
20,425,562.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,699,216,461.55 |
| Owner's Equity（Stockholder's Equity） |
2,719,642,023.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,020,001,465.01 |
